Reason for request
Inclusion
Clinical Benefit
Clinical Added Value
| no clinical added value |
NEVANAC 1 mg/ ml, eye drops, suspension does not offer any improvement in actual benefit (IAB V) over standard management of postoperative macular oedema associated with cataract surgery in diabetic patients. |
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
CsQU4b68ANKNN0YP
